Similar companies
Did Moleculin Biotech Beat Earnings?
Moleculin Biotech (MBRX) reported Q4 '25 revenue of $0, down 100.0% year-over-year, with reported EPS of $4.83. That topped the $-6.11 analyst estimate by 179.0% — an earnings beat.
AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — Moleculin Biotech’s job postings, web traffic, and employee business outlook. See the full MBRX stock analysis or the earnings calendar for upcoming reports.
Moleculin Biotech Quarterly Financial Trends
| Metric | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | 130,000 | 63,000 | — | — | — | — | — |
| Gross margin | — | -24.6% | -49.2% | — | — | — | — | — |
| Operating margin | — | -5,272.2% | -9,433.3% | — | — | — | — | — |
| Net income | -11M | -1.9M | -6.4M | -7.6M | -25M | 16M | -13M | -7.6M |
| Net margin | — | -1,493.7% | -10,215.9% | — | — | — | — | — |
| EPS | — | — | — | — | — | $4.83 | — | — |
Moleculin Biotech Earnings Trend Analysis
Over the eight quarters from Q3 '24 to Q2 '26, Moleculin Biotech’s quarterly revenue moved from $0 to $0. Moleculin Biotech has beaten Wall Street EPS estimates in 1 of its last 1 reported quarters.
When Is Moleculin Biotech’s Next Earnings Date?
Moleculin Biotech reports earnings on a quarterly schedule. Its most recent report covered Q4 '25. For the confirmed upcoming date — and every other company reporting soon — see the MBRX earnings calendar.
Frequently Asked Questions: Moleculin Biotech Earnings
Moleculin Biotech's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.
Moleculin Biotech reported Q4 '25 EPS of $4.83 on revenue of $0 (-100.0% YoY). Moleculin Biotech beat estimates, reporting $4.83 vs. the $-6.11 estimate.
Moleculin Biotech reported Q4 '25 revenue of $0, down 100.0% from the same quarter a year earlier.
Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the MBRX AI Score.
